1. Early-onset central diabetes insipidus is associated with de novo arginine vasopressin–neurophysin II or Wolfram syndrome 1 gene mutations
- Author
-
Mohamad Maghnie, Claudia Santoro, Domenico Cozzolino, Maria Carolina Salerno, Fulvio Della Ragione, Annalisa Calcagno, Saverio Scianguetta, Marta Giaccardi, Silverio Perrotta, Natascia Di Iorgi, Marco Cappa, Adriana Borriello, Flavia Napoli, Marcella Ferraro, Anna Elsa Maria Allegri, Perrotta, S, Di Iorgi, N, Ragione, Fd, Scianguetta, S, Borriello, A, Allegri, Ae, Ferraro, M, Napoli, F, Calcagno, A, Giaccardi, M, Cappa, M, Salerno, Mc, Cozzolino, D, Maghnie, M, Santoro, C., Perrotta, Silverio, Di Iorgi, Natascia, Ragione, Fulvio Della, Scianguetta, Saverio, Borriello, Adriana, Allegri, Anna Elsa Maria, Ferraro, Marcella, Santoro, Claudia, Napoli, Flavia, Calcagno, Annalisa, Giaccardi, Marta, Cappa, Marco, Salerno, Mariacarolina, Cozzolino, Domenico, and Maghnie, Mohamad
- Subjects
Adult ,Male ,medicine.medical_specialty ,Protein Precursor ,Adolescent ,Vasopressins ,Wolfram syndrome ,Endocrinology, Diabetes and Metabolism ,Neurophysin ,Mutation, Missense ,Genetic Association Studie ,Biology ,Gene mutation ,medicine.disease_cause ,Cohort Studies ,Young Adult ,Exon ,Endocrinology ,Neurophysin II ,Internal medicine ,medicine ,Humans ,Missense mutation ,Protein Precursors ,Age of Onset ,Child ,Membrane Protein ,Genetic Association Studies ,Cells, Cultured ,Neurophysins ,Mutation ,WFS1 gene ,Transition (genetics) ,Membrane Proteins ,Wolfram Syndrome ,General Medicine ,Middle Aged ,medicine.disease ,AVP-NPII gene ,Diabetes Insipidus, Neurogenic ,Diabetes insipidus ,Idiopathic early-onset central diabetes insipidu ,Female ,Cohort Studie ,Vasopressin ,hormones, hormone substitutes, and hormone antagonists ,Human - Abstract
ObjectiveIdiopathic early-onset central diabetes insipidus (CDI) might be due to mutations of arginine vasopressin–neurophysin II (AVP–NPII (AVP)) or wolframin (WFS1) genes.Design and methodsSequencing of AVP and WFS1 genes was performed in nine children with CDI, aged between 9 and 68 months, and negative family history for polyuria and polydipsia.ResultsTwo patients carried a mutation in the AVP gene: a heterozygous G-to-T transition at nucleotide position 322 of exon 2 (c.322G>T) resulting in a stop codon at position 108 (p.Glu108X), and a novel deletion from nucleotide 52 to 54 (c.52_54delTCC) producing a deletion of a serine at position 18 (p.Ser18del) of the AVP pre-prohormone signal peptide. A third patient carried two heterozygous mutations in the WFS1 gene localized on different alleles. The first change was A-to-G transition at nucleotide 997 in exon 8 (c.997A>G), resulting in a valine residue at position 333 in place of isoleucine (p.Ile333Val). The second novel mutation was a 3 bp insertion in exon 8, c.2392_2393insACG causing the addition of an aspartate residue at position 797 and the maintenance of the correct open reading frame (p. Asp797_Val798insAsp). While similar WFS1 protein levels were detected in fibroblasts from healthy subjects and from the patient and his parents, a major sensitivity to staurosporine-induced apoptosis was observed in the patient fibroblasts as well as in patients with Wolfram syndrome.ConclusionsEarly-onset CDI is associated with de novo mutations of the AVP gene and with hereditary WFS1 gene changes. These findings have valuable implications for management and genetic counseling.
- Published
- 2015
- Full Text
- View/download PDF